The application of lipase from Burkholderia cepacia in the enantioselective pharmaceutical biocatalysis
Lipases are widely applied catalysts in the pharmaceutical and biotechnological industries. They are characterized by high catalytic activity, and stability and are environmentally friendly. These enzymes could be used in free and in immobilized form. The immobilization procedure is exerted to impro...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Polish |
| Published: |
Polish Pharmaceutical Society
2022-06-01
|
| Series: | Farmacja Polska |
| Subjects: | |
| Online Access: | https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2022%2F4%2F03_OG_Lipaza_BCL_n.pdf |
| _version_ | 1798001916850995200 |
|---|---|
| author | Jacek Dulęba Tomasz Siódmiak Rafał Mastalerz Natalia Kocot Agnieszka Dębińska Emilia Suchomska Mateusz Czeczka Kamil Cała Michał Piotr Marszałł |
| author_facet | Jacek Dulęba Tomasz Siódmiak Rafał Mastalerz Natalia Kocot Agnieszka Dębińska Emilia Suchomska Mateusz Czeczka Kamil Cała Michał Piotr Marszałł |
| author_sort | Jacek Dulęba |
| collection | DOAJ |
| description | Lipases are widely applied catalysts in the pharmaceutical and biotechnological industries. They are characterized by high catalytic activity, and stability and are environmentally friendly. These enzymes could be used in free and in immobilized form. The immobilization procedure is exerted to improve enzyme activity and is carried out by different methods (e.g. physical adsorption, covalent binding, ionic interaction, encapsulation, cross-linking, entrapment). The most important lipase activities are enantioselectivity (e.g. the kinetic resolution of the racemic mixture) and lipolytic activity, enabling hydrolysis of triacylglycerol (TAG) to free fatty acids (FFA) and glycerol in an aqueous medium. One of the most commonly investigated is lipase from Burkholderia cepacia (BCL), characterized by high hydrolytic activity, regardless of the length of the organic acid chain. The enantioselectivity of BCL allows receiving chirally pure compounds in, among others, the transesterification reactions.
The review aimed to present the application of BCL in enantioselective reactions of pharmaceutical significance. Obtained using this lipase, the (R)-1-phenylethanol, is the chiral building block in drug synthesis. However, BCL has been also studied for the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs) such as (S)-ibuprofen and (S)-ketoprofen. Moreover, this enzyme has been used in the kinetic resolution of myo-inositol derivatives, applied in treating hormonal disorders, and (R,S)-mandelic acid used in dermatology. It was shown that BCL was also helpful in receiving chirally pure L-menthol, the demulcent and cooling compound in various drug forms. The application of BCL in catalyzing desymmetrization of propan-1,3-diol derivatives, applied as intermediates in various drug synthesis, has been noted. Therefore, BCL seems to be one of the most suitable catalysts for performing pharmaceutical biocatalysis and is of increasing interest to researchers and research consortia. |
| first_indexed | 2024-04-11T11:43:52Z |
| format | Article |
| id | doaj.art-e7a5146dfdd14677bf8106ef2d24abb9 |
| institution | Directory Open Access Journal |
| issn | 0014-8261 |
| language | Polish |
| last_indexed | 2024-04-11T11:43:52Z |
| publishDate | 2022-06-01 |
| publisher | Polish Pharmaceutical Society |
| record_format | Article |
| series | Farmacja Polska |
| spelling | doaj.art-e7a5146dfdd14677bf8106ef2d24abb92022-12-22T04:25:45ZpolPolish Pharmaceutical SocietyFarmacja Polska0014-82612022-06-0178419420010.32383/farmpol/151576151576The application of lipase from Burkholderia cepacia in the enantioselective pharmaceutical biocatalysisJacek Dulęba0https://orcid.org/0000-0003-1322-3820Tomasz Siódmiak1https://orcid.org/0000-0002-9232-5798Rafał Mastalerz2https://orcid.org/0000-0002-8111-8945Natalia Kocot3https://orcid.org/0000-0001-9107-263XAgnieszka Dębińska4https://orcid.org/0000-0002-6253-8506Emilia Suchomska5https://orcid.org/0000-0003-3215-3936Mateusz Czeczka6https://orcid.org/0000-0001-6303-8987Kamil Cała7https://orcid.org/0000-0002-4441-0920Michał Piotr Marszałł8https://orcid.org/0000-0001-9948-9456Katedra Chemii Leków, Wydział Farmaceutyczny, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, PolskaKatedra Chemii Leków, Wydział Farmaceutyczny, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, PolskaKatedra Chemii Leków, Wydział Farmaceutyczny, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, PolskaKatedra Chemii Leków, Wydział Farmaceutyczny, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, PolskaKatedra Chemii Leków, Wydział Farmaceutyczny, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, PolskaKatedra Chemii Leków, Wydział Farmaceutyczny, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, PolskaKatedra Chemii Leków, Wydział Farmaceutyczny, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, PolskaKatedra Chemii Leków, Wydział Farmaceutyczny, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, PolskaKatedra Chemii Leków, Wydział Farmaceutyczny, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, PolskaLipases are widely applied catalysts in the pharmaceutical and biotechnological industries. They are characterized by high catalytic activity, and stability and are environmentally friendly. These enzymes could be used in free and in immobilized form. The immobilization procedure is exerted to improve enzyme activity and is carried out by different methods (e.g. physical adsorption, covalent binding, ionic interaction, encapsulation, cross-linking, entrapment). The most important lipase activities are enantioselectivity (e.g. the kinetic resolution of the racemic mixture) and lipolytic activity, enabling hydrolysis of triacylglycerol (TAG) to free fatty acids (FFA) and glycerol in an aqueous medium. One of the most commonly investigated is lipase from Burkholderia cepacia (BCL), characterized by high hydrolytic activity, regardless of the length of the organic acid chain. The enantioselectivity of BCL allows receiving chirally pure compounds in, among others, the transesterification reactions. The review aimed to present the application of BCL in enantioselective reactions of pharmaceutical significance. Obtained using this lipase, the (R)-1-phenylethanol, is the chiral building block in drug synthesis. However, BCL has been also studied for the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs) such as (S)-ibuprofen and (S)-ketoprofen. Moreover, this enzyme has been used in the kinetic resolution of myo-inositol derivatives, applied in treating hormonal disorders, and (R,S)-mandelic acid used in dermatology. It was shown that BCL was also helpful in receiving chirally pure L-menthol, the demulcent and cooling compound in various drug forms. The application of BCL in catalyzing desymmetrization of propan-1,3-diol derivatives, applied as intermediates in various drug synthesis, has been noted. Therefore, BCL seems to be one of the most suitable catalysts for performing pharmaceutical biocatalysis and is of increasing interest to researchers and research consortia.https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2022%2F4%2F03_OG_Lipaza_BCL_n.pdfimmobilizationchiral drugslipase from burkholderia cepaciaenantioselectivitychiral intermediates |
| spellingShingle | Jacek Dulęba Tomasz Siódmiak Rafał Mastalerz Natalia Kocot Agnieszka Dębińska Emilia Suchomska Mateusz Czeczka Kamil Cała Michał Piotr Marszałł The application of lipase from Burkholderia cepacia in the enantioselective pharmaceutical biocatalysis Farmacja Polska immobilization chiral drugs lipase from burkholderia cepacia enantioselectivity chiral intermediates |
| title | The application of lipase from Burkholderia cepacia in the enantioselective pharmaceutical biocatalysis |
| title_full | The application of lipase from Burkholderia cepacia in the enantioselective pharmaceutical biocatalysis |
| title_fullStr | The application of lipase from Burkholderia cepacia in the enantioselective pharmaceutical biocatalysis |
| title_full_unstemmed | The application of lipase from Burkholderia cepacia in the enantioselective pharmaceutical biocatalysis |
| title_short | The application of lipase from Burkholderia cepacia in the enantioselective pharmaceutical biocatalysis |
| title_sort | application of lipase from burkholderia cepacia in the enantioselective pharmaceutical biocatalysis |
| topic | immobilization chiral drugs lipase from burkholderia cepacia enantioselectivity chiral intermediates |
| url | https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2022%2F4%2F03_OG_Lipaza_BCL_n.pdf |
| work_keys_str_mv | AT jacekduleba theapplicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT tomaszsiodmiak theapplicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT rafałmastalerz theapplicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT nataliakocot theapplicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT agnieszkadebinska theapplicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT emiliasuchomska theapplicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT mateuszczeczka theapplicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT kamilcała theapplicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT michałpiotrmarszałł theapplicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT jacekduleba applicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT tomaszsiodmiak applicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT rafałmastalerz applicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT nataliakocot applicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT agnieszkadebinska applicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT emiliasuchomska applicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT mateuszczeczka applicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT kamilcała applicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis AT michałpiotrmarszałł applicationoflipasefromburkholderiacepaciaintheenantioselectivepharmaceuticalbiocatalysis |